Gosline works to develop computational algorithms that are uniquely targeted for rare disease work by doing foundational research in model system development. This work can be expanded to all model systems in human disease.

Data-driven autonomous technology to rapidly design and deliver antiviral interventions targeting SARS-CoV-2 to reduce drug discovery timeline and advance bio preparedness capabilities.

Advanced proteomic analysis tools dig deep into human blood plasma to understand the molecular nature of advanced alcoholic disease.

PNNL Biomedical Scientist Geremy Clair has taken on new roles as an editor for two journals; Frontiers In Cellular And Infection Microbiology and Frontiers In Molecular Biosciences.

Clarivate recently released the list of Highly Cited Researchers for 2022.

The Joint Appointment program at PNNL is one of the most diverse among other U.S. national laboratories, involving nearly 60 universities and research institutions in the United States and abroad.

New research findings published in Science Advances (November 2022), help explain the progression of Alzheimer-related dementia in each patient. The findings outline a biological classification system that predicts disease severity.

Silicone wristbands could be more convenient option for collecting exposure data.

Customized molecular tools identify specific microbial functions that are key to healthy people and environments.

PNNL combines AI and cloud computing with damage assessment tool to predict path of wildfires and quickly evaluate the impact of natural disasters, giving first responders an upper hand.

A new article reviews bio-orthogonal click chemistry reagents that can be used as probes to label metabolic pathways in plants and microbes.

PNNL designed a free, web-based tool to visually explore the National Response Framework.

Ann Lesperance, national security advisor, joins the National Academies of Sciences, Engineering, and Medicine Committee on Applied Research Topics for Hazard Mitigation and Resilience.